Centric Wealth Management Purchases New Stake in Molina Healthcare, Inc $MOH

Centric Wealth Management purchased a new stake in shares of Molina Healthcare, Inc (NYSE:MOH) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 2,798 shares of the company’s stock, valued at approximately $547,000.

Several other hedge funds have also added to or reduced their stakes in the business. Torren Management LLC acquired a new position in shares of Molina Healthcare in the fourth quarter valued at $26,000. Physician Wealth Advisors Inc. lifted its stake in shares of Molina Healthcare by 1,250.0% during the 1st quarter. Physician Wealth Advisors Inc. now owns 216 shares of the company’s stock worth $29,000 after buying an additional 200 shares during the last quarter. Quarry LP acquired a new stake in shares of Molina Healthcare during the 4th quarter worth about $32,000. SJS Investment Consulting Inc. boosted its holdings in shares of Molina Healthcare by 504.9% during the 1st quarter. SJS Investment Consulting Inc. now owns 248 shares of the company’s stock worth $33,000 after buying an additional 207 shares during the period. Finally, Elevation Wealth Partners LLC boosted its holdings in shares of Molina Healthcare by 118.2% during the 2nd quarter. Elevation Wealth Partners LLC now owns 144 shares of the company’s stock worth $33,000 after buying an additional 78 shares during the period. Institutional investors and hedge funds own 98.50% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on MOH shares. UBS Group upped their price target on shares of Molina Healthcare from $180.00 to $202.00 and gave the company a “neutral” rating in a research note on Friday, May 22nd. Morgan Stanley boosted their price objective on Molina Healthcare from $146.00 to $167.00 and gave the stock an “equal weight” rating in a report on Thursday, June 4th. Robert W. Baird upped their target price on Molina Healthcare from $124.00 to $163.00 and gave the company a “neutral” rating in a research report on Monday, May 11th. Cantor Fitzgerald reiterated a “neutral” rating on shares of Molina Healthcare in a research note on Friday, July 24th. Finally, Bank of America raised Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 price target for the company in a report on Wednesday, April 29th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $202.44.

Molina Healthcare Price Performance

Shares of Molina Healthcare stock opened at $212.24 on Friday. Molina Healthcare, Inc has a twelve month low of $121.06 and a twelve month high of $244.89. The company has a quick ratio of 1.68, a current ratio of 1.68 and a debt-to-equity ratio of 0.95. The company has a 50-day simple moving average of $210.98 and a two-hundred day simple moving average of $178.08. The stock has a market capitalization of $11.08 billion, a price-to-earnings ratio of -1,179.07, a price-to-earnings-growth ratio of 30.44 and a beta of 0.75.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings data on Wednesday, July 22nd. The company reported $1.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.12. Molina Healthcare had a negative net margin of 0.02% and a positive return on equity of 3.73%. The firm had revenue of $10.87 billion during the quarter, compared to the consensus estimate of $10.83 billion. During the same quarter in the previous year, the firm posted $5.48 EPS. The business’s revenue for the quarter was down 4.8% compared to the same quarter last year. Analysts forecast that Molina Healthcare, Inc will post 5.29 EPS for the current year.

More Molina Healthcare News

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Zacks Research raised multiple future EPS forecasts and reiterated a “Strong-Buy” rating. Estimates increased for Q4 2026 to $0.70 from $0.53, Q1 2027 to $2.53 from $1.60, Q2 2027 to $2.22 from $1.82, Q4 2027 to $2.87 from $2.00, FY2027 to $10.05 from $7.61, and FY2028 to $11.94 from $9.76. The revisions suggest analysts see stronger earnings power beyond the near term, although the current-year consensus remains $5.29 per share.
• Positive Sentiment: Recent quarterly results and raised guidance are supporting a recovery in sentiment. Molina reported second-quarter adjusted EPS of $1.51, above expectations, and increased its minimum 2026 adjusted earnings outlook to $5.25 from $5.00. Investors appear to be reassessing the stock after its post-earnings selloff, with Medicaid policy clarity and resilient profitability helping drive the rebound. Molina Healthcare Surged on Medicaid Clarity and Robust Results
• Positive Sentiment: Investor interest from Michael Burry provides an additional sentiment boost. Burry reportedly added to his Molina position at approximately $198, signaling confidence in the company’s valuation and longer-term healthcare prospects ahead of election-related Medicaid policy discussions. Michael Burry Adds to Molina Healthcare Position
• Neutral Sentiment: Not all estimate changes were favorable. Zacks reduced its Q3 2026 EPS forecast to $0.72 from $1.07 and cut Q2 2028 EPS to $2.30 from $2.60, underscoring continuing near-term earnings and cost pressures.
• Negative Sentiment: Insider transactions were weighted toward selling. Company insiders recorded three sales versus one purchase over the past six months, a potentially cautious signal, though these transactions do not necessarily reflect management’s outlook.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.